Mario Gabelli's position in Biomarin Pharmaceutical - Registered Shares is currently worth $601 Thousand. That's 0.01% of their equity portfolio (619th largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q4 2017. Since then Mario Gabelli bought shares nine more times and sold shares on twelve occasions. The investor's estimated purchase price is $780 Thousand, resulting in a loss of 23%.